289 related articles for article (PubMed ID: 16893759)
1. Mechanisms of insulin resistance in hypertensive rats.
Shimamoto K; Ura N
Clin Exp Hypertens; 2006 Aug; 28(6):543-52. PubMed ID: 16893759
[TBL] [Abstract][Full Text] [Related]
2. Metabolic stress with a high carbohydrate diet increases adiponectin levels.
Kamari Y; Grossman E; Oron-Herman M; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Horm Metab Res; 2007 May; 39(5):384-8. PubMed ID: 17533582
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome: comparison of the two commonly used animal models.
Oron-Herman M; Kamari Y; Grossman E; Yeger G; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Am J Hypertens; 2008 Sep; 21(9):1018-22. PubMed ID: 18566592
[TBL] [Abstract][Full Text] [Related]
4. Dietary conjugated linoleic acid lowered tumor necrosis factor-alpha content and altered expression of genes related to lipid metabolism and insulin sensitivity in the skeletal muscle of Zucker rats.
Inoue N; Nagao K; Wang YM; Noguchi H; Shirouchi B; Yanagita T
J Agric Food Chem; 2006 Oct; 54(20):7935-9. PubMed ID: 17002473
[TBL] [Abstract][Full Text] [Related]
5. Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.
Comte C; Bellenger S; Bellenger J; Tessier C; Poisson JP; Narce M
Biochimie; 2004 Nov; 86(11):799-806. PubMed ID: 15589689
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
[TBL] [Abstract][Full Text] [Related]
9. Role of abnormalities of carbohydrate and lipoprotein metabolism in the pathogenesis and clinical course of hypertension.
Reaven GM
J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S4-7. PubMed ID: 1694930
[TBL] [Abstract][Full Text] [Related]
10. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
[TBL] [Abstract][Full Text] [Related]
11. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of cardiovascular risk factor clustering in spontaneous hypertension.
Pravenec M; Zídek V; Landa V; Kostka V; Musilová A; Kazdová L; Fucíková A; Krenová D; Bíla V; Kren V
Folia Biol (Praha); 2000; 46(6):233-40. PubMed ID: 11140856
[TBL] [Abstract][Full Text] [Related]
13. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome.
Dekker MJ; Su Q; Baker C; Rutledge AC; Adeli K
Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E685-94. PubMed ID: 20823452
[TBL] [Abstract][Full Text] [Related]
14. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
15. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats.
Rodríguez A; Catalán V; Becerril S; Gil MJ; Mugueta C; Gómez-Ambrosi J; Frühbeck G
Life Sci; 2008 Oct; 83(15-16):540-9. PubMed ID: 18761357
[TBL] [Abstract][Full Text] [Related]
16. Fructose and metabolic diseases: new findings, new questions.
Tappy L; Lê KA; Tran C; Paquot N
Nutrition; 2010; 26(11-12):1044-9. PubMed ID: 20471804
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
Kopp W
Med Hypotheses; 2005; 64(4):782-7. PubMed ID: 15694697
[TBL] [Abstract][Full Text] [Related]
18. [Development of animal models for the metabolic syndrome with hypertension].
Fukuda N
Nihon Rinsho; 2006 Jul; 64 Suppl 5():300-2. PubMed ID: 16895197
[No Abstract] [Full Text] [Related]
19. Dietary fructose and the metabolic syndrome.
Miller A; Adeli K
Curr Opin Gastroenterol; 2008 Mar; 24(2):204-9. PubMed ID: 18301272
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
